Skip to main content

Table 2 Baseline characteristics of patients excluded due to any reasona

From: Memantine in patients with Alzheimer's disease receiving donepezil: new analyses of efficacy and safety for combination therapy

  All excluded patients
Characteristic Memantine
( n = 156)
Placebo
( n = 171)
Female 91 (58.3) 92 (53.8)
Age, mean (SD) years 75.4 (7.3) 75.7 (8.7)
Caucasian 147 (94.2) 162 (94.7)
Black 4 (2.6) 3 (1.8)
Asian 0 (0.0) 1 (0.6)
Other 5 (3.2) 5 (2.9)
MMSE score, mean (SD) 17.9 (4.0) 18.0 (3.6)
  1. Data are number (%) unless otherwise specified. aExclusion criteria were mild Alzheimer's disease (MMSE ≥ 20 at baseline), receiving a cholinesterase inhibitor other than donepezil, or receiving donepezil at a dose < 10 mg/day. MMSE, Mini-Mental State Examination.